Table 3 Significant prognostic factors for breast cancer specific survival in univariate analysis
num. | 5 yr BCSS* (%) | 10 yr BCSS* (%) | p | ||
|---|---|---|---|---|---|
Age | ≤40 | 49 | 80.7 | 67.9 | 0.009 |
>40 | 1109 | 90.1 | 80.3 | ||
multifocal/multicentric breast cancer | No | 967 | 91.7 | 82.7 | <0.001 |
Yes | 191 | 79.4 | 72.5 | ||
Tumor size | 1a (0.1 – 0.5 cm) | 53 | 100 | 83.3 | <0.001 |
1b (0.6 – 1 cm) | 200 | 97.3 | 91.5 | ||
1c (1.1 – 2 cm) | 484 | 92.3 | 83.9 | ||
2 (2.1 – 5 cm) | 325 | 87.7 | 74.1 | ||
3 (>5 cm) | 96 | 62.4 | 39.8 | ||
pN | 0 | 699 | 95.6 | 89.1 | <0.001 |
1 a | 240 | 92.8 | 81.1 | ||
2 a | 132 | 81 | 65.6 | ||
3 a | 87 | 53 | 31.4 | ||
Tumor Grade | G1 | 215 | 92 | 87 | 0.02 |
G2 | 653 | 90.3 | 81.1 | ||
G3 | 290 | 86.5 | 67.5 | ||
Lymphovascular invasion | Absent | 746 | 93.4 | 84.1 | 0.001 |
Present | 357 | 81.6 | 69.7 | ||
Estrogen receptors | positive | 356 | 93.3 | 82 | <0.001 |
negative | 716 | 82.3 | 74.2 | ||
Mib-1 | <15% | 506 | 95.8 | 86.7 | <0.001 |
>15% | 559 | 88.3 | 69.9 |